二甲双胍对破骨细胞体外分化的影响  

Effects of metformin on osteoclasts differentiation in vitro

作　　者：陆明[1] 徐颂[1] 麦奇光[1] 周荣平[1] 张忠民[1] 王亮[1] 黄敏军[1] 王小开[1] 金大地[1] 

机构地区：[1]南方医科大学第三附属医院骨科,广州510630

出　　处：《中华骨科杂志》2011年第5期535-541,共7页Chinese Journal of Orthopaedics

基　　金：国家自然科学基金（30973036）

摘　　要：目的 探讨二甲双胍对破骨细胞体外分化的影响及其可能机制.方法 采用RANKL诱导鼠巨噬细胞系Raw264.7细胞破骨分化模型,给予不同浓度的二甲双胍（400 μmol/L、800 μmol/L和1000μmol/L）和雷帕霉素（100 hmol/L）处理后,通过抗酒石酸酸性磷酸酶（tartrate-resistant Acid Phosphatase,TRAP）染色和破骨细胞骨架结构荧光染色观察破骨细胞数量,骨吸收培养板观察骨陷窝面积,RT-PCR技术检测破骨细胞特异性基因TRAP、组织蛋白酶K、降钙素受体和金属基质蛋白酶-9的表达,ELISA法检测肿瘤坏死因子-α（tumor necrosis factor,TNF-α）表达水平,Western-b1ot检测c-Fos蛋白以及哺乳动物雷帕霉素靶蛋白（mammalian target of rapamycin complex l,mTORC1）信号通路下游底物S6K1 Thr389、S6 Ser235/236、4EBP1 Thr37/46的表达及磷酸化水平.结果 二甲双胍和雷帕霉素均可使RANKL诱导的破骨细胞数量减少,抑制破骨细胞特异性基因的表达、抑制TNF-α、c-Fos蛋白以及mTORC1信号通路下游底物S6K1 Thr389、S6 Ser235/236、4E-BP1 Thr37/46的磷酸化,且二甲双胍的抑制作用具有浓度依赖性.结论 二甲双胍可抑制RANKL诱导的破骨前体细胞分化,其机制可能与抑制TNF-α和c-Fos蛋白的生成,以及抑制mTORC1信号通路激活有关.Objective To investigate the effects of mefformin on the differentiation of osteoclastas well as relative mechanism.Methods Raw264.7 cells from the murine macrophage cell line was used.Receptor activator of NF-κB ligand （RANKL） was used to stimulate osteoclast differentiation from Raw264.7 cells.Osteoclast differentiation was assessed by tartrate-resistant acid phosphatase （TRAP） and actin fluorescence staining and counting the TRAP-positive cells after exposure to different concentrations of mefformin （0 μmol/L,400 μmol/L,800 μmol/L and 1000 μmol/L） or rapamicin （100 nmol/L） in the presence of 50 ng/ml RANKL for 5 days.Bone-resorbing activity was evaluated by BD BioCoatTM OsteologicTM Bone Cell Culture System.The expression of osteoclast-specific genes like TRAP,capthesin K,calcitonin receptor （CTR） and matrix metalloproteinase （MMP-9） was evaluated by RT-PCR.The expression of tumor necrosis factor-α（TNF-ct） S6K1Thr389,S6 Ser235/236,4E-BP1Thr37/46 and c-Fos protein was evaluated by ELISA kit and Western blot analysis,respectively.Results Mefformin dose-dependently inhibited RANKL-stimulated osteoclasts differentiation in Raw264.7 cell culture,as manifested by decrease of TRAP-positive multinucleated cells and pit erosion area,down-regulation of TRAP,cathepsin K,CTR and MMP-9 mRNA and reduction of TNF-α and c-Fos protein expression.Further study revealed that RANKL activated mTOR complex 1（mTORC1） signaling,while mefformin impaired RANKL-stimulated mTORC1 signaling.Rapamycin,an mTORCl-specific inhibitor and immunosuppressive macrolides could also prevent RANKL-induced osteoclast differentiation and bone resorption in vitro.Conclusion Mefformin inhibits osteoclastogenesis in vitro,which may due to reduction of TNF-α and c-Fos protein expression,and mTORC1 signaling is involved in this process.

关 键 词：破骨细胞 二甲双胍 细胞分化 

分 类 号：R965[医药卫生—药理学]